ATG9B Antibody: ATTO 390

Rabbit Anti-Human ATG9B Polyclonal

Target: ATG9B.

Conjugate: ATTO 390.

Product Type: Polyclonal.

Immunogen: Synthetic peptide from the N-terminal of Human ATG9B (aa. 110-121).

Swiss-Prot: Q674R7.

Purification: Peptide Affinity Purified.

Storage Buffer: PBS, 50% glycerol, 0.09% sodium azide.

Concentration: 1 mg/ml.

Specificity: Detects ~100 kDa.

Cellular Localization: Cytoplasmic Vesicle, Autophagosome Membrane, Multi-Pass Membrane Protein.

Tissue Specificity: Highly expressed in placenta (trophoblast cells) and pituitary gland. Not expressed in vascular endothelial.

Scientific Background: ATG9B is involved in autophagy and cytoplasm to vacuole transport (Cvt) vesicle formation. Plays a key role in the organization of the preautophagosomal structure/phagophore assembly site (PAS), the nucleating site for formation of the sequestering vesicle. Highly expressed in the placenta and the pituitary gland.

References: 1. http://www.uniprot.org/uniprot/Q674R7.

Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• Artikelnummer: STRSPC-646D-A390
• Hersteller: Stressmarq Biosciences
• Hersteller Artikelnummer: SPC-646D-A390
• Green Labware: Nein
• Verpackungseinheit: 100 µg
• Mengeneinheit: STK
• Reaktivität: Human, Mouse (Murine)
• Klonalität: Polyclonal
• Methode: Immunofluorescence, Western Blotting, Immunocytochemistry
• Human Gene ID: 285973
• Wirt: Rabbit